Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells

Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells. Duangjai, A; Luo, K; Zhou, Y; Yang, J; and KOPECEK, J Eur J Pharm Biopharm, 87(1):187--196, May, 2014.
bibtex

@article{ Duangjai:2014fxa,
  author = {Duangjai, A and Luo, K and Zhou, Y and Yang, J and KOPECEK, J},
  title = {{Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cells}},
  journal = {Eur J Pharm Biopharm},
  year = {2014},
  volume = {87},
  number = {1},
  pages = {187--196},
  month = {May},
  annote = {Duangjai, Acharaporn
Luo, Kui
Zhou, Yan
Yang, Jiyuan
Kopecek, Jindrich
eng
P30 CA042014/CA/NCI NIH HHS/
R01 CA051578/CA/NCI NIH HHS/
R01 CA51578/CA/NCI NIH HHS/
R41 CA156933/CA/NCI NIH HHS/
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Netherlands
2013/12/10 06:00
Eur J Pharm Biopharm. 2014 May;87(1):187-96. doi: 10.1016/j.ejpb.2013.11.008. Epub 2013 Dec 4.}
}

Downloads: 0